For biopharma companies, the past decade was filled with momentous events in the legal realm, from creation of a new way to challenge patents to the emergence of biosimilar litigation and generic price-fixing suits. Below is a look at major milestones of this era.
The most significant development in patent law was the passage of the America Invents Act of 2011
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?